LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · Real-Time Price · USD
79.59
-1.08 (-1.34%)
Sep 8, 2026, 4:00 PM EDT - Market closed
LeMaitre Vascular Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 262.43 | 249.6 | 219.86 | 193.48 | 161.65 | 154.42 | |
Revenue Growth | 11.85% | 13.53% | 13.63% | 19.69% | 4.68% | 19.37% |
Cost of Revenue | 73.83 | 73.76 | 68.96 | 66.44 | 56.76 | 53.04 |
Gross Profit | 188.61 | 175.84 | 150.9 | 127.05 | 104.9 | 101.38 |
Selling, General & Admin | 100.38 | 98.29 | 83 | 72.89 | 61.67 | 53.16 |
Research & Development | 15.71 | 14.44 | 15.65 | 16.97 | 13.29 | 11.8 |
Operating Expenses | 116.09 | 112.73 | 98.65 | 89.85 | 74.96 | 64.96 |
Operating Income | 72.52 | 63.11 | 52.26 | 37.2 | 29.94 | 36.43 |
Interest Expense | -5.2 | -5.18 | -0.21 | - | - | -2.22 |
Interest & Investment Income | 13.92 | 13.09 | 4.95 | 3.08 | 0.99 | 0.2 |
Other Non Operating Income (Expenses) | -0.77 | -0.1 | -0.13 | -0.31 | -0.33 | -0.12 |
EBT Excluding Unusual Items | 80.47 | 70.92 | 56.88 | 39.96 | 30.6 | 34.29 |
Merger & Restructuring Charges | - | - | - | -0.49 | -3.11 | - |
Gain (Loss) on Sale of Investments | -0.54 | -0.54 | - | - | - | - |
Other Unusual Items | 4.8 | 4.8 | - | - | - | - |
Pretax Income | 84.73 | 75.18 | 56.88 | 39.48 | 27.49 | 34.29 |
Income Tax Expense | 19.06 | 17.45 | 12.84 | 9.37 | 6.85 | 7.38 |
Net Income | 65.67 | 57.73 | 44.04 | 30.11 | 20.64 | 26.91 |
Net Income to Common | 65.67 | 57.73 | 44.04 | 30.11 | 20.64 | 26.91 |
Net Income Growth | 39.39% | 31.10% | 46.28% | 45.89% | -23.31% | 26.80% |
Shares Outstanding (Basic) | 23 | 23 | 22 | 22 | 22 | 21 |
Shares Outstanding (Diluted) | 24 | 23 | 23 | 22 | 22 | 21 |
Shares Change | 3.65% | 0.66% | 1.59% | 1.14% | 3.24% | 4.86% |
EPS (Basic) | 2.89 | 2.55 | 1.96 | 1.36 | 0.94 | 1.27 |
EPS (Diluted) | 2.86 | 2.52 | 1.93 | 1.34 | 0.93 | 1.25 |
EPS Growth | 39.39% | 30.57% | 44.03% | 44.09% | -25.60% | 20.19% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 73.83 | 74.47 | 37.16 | 29.49 | 22.15 | 30.22 |
Free Cash Flow Per Share | 3.11 | 3.25 | 1.63 | 1.31 | 1.00 | 1.41 |
Dividend Per Share | 0.900 | 0.800 | 0.640 | 0.560 | 0.500 | 0.440 |
Dividend Growth | 25.00% | 25.00% | 14.29% | 12.00% | 13.64% | 15.79% |
Gross Margin | 71.87% | 70.45% | 68.63% | 65.66% | 64.89% | 65.65% |
Operating Margin | 27.63% | 25.29% | 23.77% | 19.23% | 18.52% | 23.59% |
Profit Margin | 25.02% | 23.13% | 20.03% | 15.56% | 12.77% | 17.42% |
Free Cash Flow Margin | 28.13% | 29.84% | 16.90% | 15.24% | 13.70% | 19.57% |
EBITDA | 83.02 | 73.53 | 61.86 | 46.71 | 39.37 | 47.5 |
EBITDA Margin | 31.64% | 29.46% | 28.14% | 24.14% | 24.35% | 30.76% |
D&A For EBITDA | 10.5 | 10.42 | 9.61 | 9.52 | 9.43 | 11.07 |
EBIT | 72.52 | 63.11 | 52.26 | 37.2 | 29.94 | 36.43 |
EBIT Margin | 27.63% | 25.29% | 23.77% | 19.23% | 18.52% | 23.59% |
Effective Tax Rate | 22.50% | 23.21% | 22.57% | 23.74% | 24.93% | 21.52% |
Advertising Expenses | - | - | - | - | 0.2 | 0.24 |